The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers

By Kaufman Bella  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 521-527

Springer Publishing Company

Access to resources Recommend Favorite

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 221-227

Springer Publishing Company

Access to resources Recommend Favorite

Association between the T27C polymorphism in the cytochrome P450 c17 α ( CYP17 ) gene and risk factors for breast cancer

By Hong Chi-chen  

Breast Cancer Research and Treatment, Vol. 88, Iss. 3, 2004-12 ,pp. : 217-230

Springer Publishing Company

Access to resources Recommend Favorite

The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women

By Li Hongxia   Feng Liya   Xu Ye   Yao Lihua   Ouyang Tao   Li Jinfeng   Wang Tianfeng   Fan Zhaoqing   Lin Benyao   Li Jiyou   Xie Yuntao  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 597-601

Informa Healthcare

Access to resources Recommend Favorite

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls

By Mao Chen  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 259-265

Springer Publishing Company

Access to resources Recommend Favorite